In today ‘ s society, coronary heart disease has become one of the major cardiovascular diseases that threaten human health. And its hidden coronary heart disease, because of its anomalous symptoms, is often like a bomb hidden in the dark, threatening the life of the patient.
Concealmentary coronary heart disease, also known as non-asymptomatic coronary heart disease, refers to the absence of subjective symptoms, such as chest pain or symptoms related to myocardial insufficiency, due to the fact that there is objective evidence of a change in myocardial myocardial blood (e.g., through electrocardiograms, radionucleus myocardiology or left heart function determination), which, according to statistics, in clinical terms, represents a significant proportion of coronary heart patients who are invisible, and this data shows that they have a high incidence and are susceptible to neglect.
The formation of hidden coronary heart disease is a more complex process in terms of the mechanism of morbidity. Sclerosis of coronary porridge is a major pathological factor. In the early stages of the disease, lipid deposition and the emergence of plasters resulted in a narrow coronary vascular wall. However, as a result of the human body ‘ s own mechanisms of reparative action, symptoms such as palpitation may not be apparent when the coronary artery is not so narrow as to seriously affect myocardial blood. For example, the coronary artery of the heart has a side cycle, which, in the case of narrow aortic arteries, can provide some additional blood supply to temporarily maintain the normal function of the cardiac muscle. However, there are limits to this compensation, and as the disease progresses, myocardial hemorrhage occurs when the oxygen supply and demand balance of myocardial muscles is broken, such as in cases of motorization, emotional agitation, fatigue, etc., when the heart load increases, even though the patient may still have no apparent self-conscious symptoms.
There is some challenge in the diagnosis of hidden coronary heart disease. One of the important ways to detect hidden coronary heart disease is through routine electrocardiograms. Some people with hidden coronary heart diseases may be normal in a static state, but in the conduct of motor load tests, they may induce changes in the EKG of myocardial insemination, as a result of increased aerobic consumption of myocardial muscles due to increased motor strength. In addition, dynamic electrocardiogram monitoring, which keeps the EKG for 24 hours or more on a continuous basis, can help to detect short-lived cardiac insemination and capture evidence of possible myocardial insemination in patients ‘ daily activities. Radionucleus myocardial injections are of significant value for the determination of the existence and extent of myocardial insufficiency, and can be visualized to show myocardial blood flow. The structure and function of the heart can be assessed by means of an ultrasound cardiac examination, which can indirectly determine the presence or absence of ischaemic blood in the cardiac muscle by observing its motion.
Although there are no visible signs of coronary pain in persons with hidden coronary heart, there are still some detectable symptoms. Certain patients may experience non-characteristic symptoms, such as unspecified fatigue, inactivity, respiratory rush and heart attack. These symptoms are often neglected or mispercepted by patients as other diseases, such as respiratory diseases, menopause symptoms, etc., causing the patient to deteriorate and delay treatment. For example, a middle-aged male patient, who in recent months has often suffered from fatigue, short post-activity, perceived as a result of high work stress and lack of exercise, has been neglected. It was not until the unit organized a medical examination and carried out an electrocardiogram exercise to detect the presence of myocardial ischaemic blood and further examination to identify it as hidden coronary heart disease.
The hidden harm of coronary heart disease cannot be underestimated, and as the patient does not have a visible early warning signal of heart pain, myocardiosis may continue unwittingly, causing heart cell damage, myocardial fibrosis and, consequently, the function of the heart. Long-term myocardiosis also increases the risk of cardiac disorders, with fatal cardiac disorders such as hypervelocity, CPRs, etc. Concealed coronary heart disease is also a potential risk factor for myocardial infarction, which, when it occurs, tends to be dangerous and less dangerous.
The treatment of hidden coronary heart disease is primarily to prevent myocardial infarction and sudden death, thus improving the patient ‘ s prognosis. First, lifestyle interventions are essential. Patients should stop drinking alcohol, which is an important risk factor in accelerating the coronary porridge sclerosis of cardiovascular disease; drinking is not too much. Eat well, reduce saturated fatty acids and cholesterol and increase diet-rich foods, such as fruit and vegetables, while controlling weight and avoiding obesity. Routine exercise helps to improve the cycling of the heart function and coronary artery, but the strength of the activity should be individualized according to the patient ‘ s specific circumstances, avoiding overwork leading to myocardial insufficiency.
The treatment of hidden coronary heart disease is centred on drug treatment, and anti-sculpable tablet drugs such as aspirin, chlorprorey, etc. can inhibit condensate, stop the formation of leopardism and reduce the chance of myocardial infarction. Histogens can reduce blood resin, and steady coronary laceration slows progress in the sclerosis of the artery. Beta Receptor breakers are also resistant to arrhythmia while reducing myocardial oxygen and improving myocardial insemination. For the improvement of the cardiac function and reduction of myocardial reorganisation, an vascular stressor conversion enzyme inhibitor or an vascular stressor II receptor resistance.
In cases where the coronary artery is very narrow and the drug treatment is ineffective, intervention (e.g., coronary artery stifling) or coronary artery by-pass transplant (bridge surgery) may need to be considered. These treatments can lead to the re-establishment of the blood flow of the coronary artery, an improvement in the availability of myocardial blood and a consequent reduction in the probability of cardiovascular incidents.
Self-management of hidden coronary heart patients is also important. Patients should regularly visit the hospital for review, including EKG, cardiac ultrasound, blood resin, blood sugar etc., in order to detect changes in the condition in time and to adjust the treatment programme. At the same time, the activity should cease immediately if there is a slight ecstasy, agitation, etc., after identification activities, such as certain signs of myocardial insemination when requiring drugs such as nitrate glycerine. Because emotional agitation causes a sense of neurological excitement, increases blood pressure, increases heart rate and increases myocardiosis, it is important to maintain a good psychological state and discourages excessive volatility.
Despite the hidden coronary heart disease, effective control of the disease, reduction of the risk of cardiovascular incidents, improvement of the quality of life of the patient and longer life are achieved by increasing the patient ‘ s knowledge and awareness of the disease, early diagnosis and enhanced comprehensive treatment. Today, as medical technology evolves, we have more means to detect and respond to this potential health threat, so that patients can be able to return to healthy lives with appropriate intervention and management at an early stage.
